These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38064396)

  • 21. Perception and willingness toward various immunization routes for COVID-19 vaccines: a cross-sectional survey in China.
    Wang H; Cui M; Li S; Wu F; Jiang S; Chen H; Yuan J; Sun C
    Front Public Health; 2023; 11():1192709. PubMed ID: 37818300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intention to receive a COVID-19 vaccine booster dose and associated factors in Malaysia.
    Wong LP; Alias H; Siaw YL; Muslimin M; Lai LL; Lin Y; Hu Z
    Hum Vaccin Immunother; 2022 Nov; 18(5):2078634. PubMed ID: 35648441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Willingness toward COVID-19 vaccination, coadministration with other vaccines and receive a COVID-19 vaccine booster: a cross-sectional study on the guardians of children in China.
    Ma L; Yang J; Zhang T; Han X; Huang Q; Yang Y; Feng L; Yang W; Wang C
    Hum Vaccin Immunother; 2022 Nov; 18(5):2049169. PubMed ID: 35417663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Will People Accept a Third Booster Dose of the COVID-19 Vaccine? A Cross-Sectional Study in China.
    Sun Y; Dai H; Wang P; Zhang X; Cui D; Huang Y; Zhang J; Xiang T
    Front Public Health; 2022; 10():914950. PubMed ID: 35903387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preference and Willingness to Pay for the Regular COVID-19 Booster Shot in the Vietnamese Population: Theory-Driven Discrete Choice Experiment.
    Tran BX; Do AL; Boyer L; Auquier P; Le HT; Le Vu MN; Dang THT; Cao KM; Le LDT; Cu LTN; Ly BV; Nguyen DAT; Nguyen MD; Latkin CA; Ho RCM; Ho CSH; Zhang MWB
    JMIR Public Health Surveill; 2023 Jan; 9():e43055. PubMed ID: 36599156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The acceptance to heterologous booster vaccination of COVID-19 vaccine among HCWs and targeted population: A cross-sectional study in central China.
    Qin W; Zhang X; Wang Y; Pan F; Cheng K; Huang F; Song J; Su H
    Front Public Health; 2022; 10():943876. PubMed ID: 35979461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disparities in child and adolescent COVID-19 vaccination coverage and parental intent toward vaccinations for their children and adolescents.
    Nguyen KH; Levisohn A; McChesney C; Vasudevan L; Bednarczyk RA; Corlin L
    Ann Med; 2023 Dec; 55(1):2232818. PubMed ID: 37449878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors associated with COVID-19 booster vaccine hesitancy: a nationwide, cross-sectional survey in Japan.
    Takamatsu A; Honda H; Miwa T; Tabuchi T; Taniguchi K; Shibuya K; Tokuda Y
    Public Health; 2023 Oct; 223():72-79. PubMed ID: 37619504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SARS-CoV-2 variants and the global pandemic challenged by vaccine uptake during the emergence of the Delta variant: A national survey seeking vaccine hesitancy causes.
    AlJamaan F; Temsah MH; Alhasan K; Alenezi S; Alhaboob A; Alrabiaah A; Batais M; Alshahrani F; Assiri RA; Bafaqih H; Alaraj A; Al Qadrah B; Alhaidary A; Saad K; Saddik B; Halwani R; Rabaan AA; Al-Subaie S; Barry M; Al-Tawfiq JA
    J Infect Public Health; 2022 Jul; 15(7):773-780. PubMed ID: 35728424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Jordanians' willingness to receive heterologous prime-boost COVID-19 vaccination and vaccine boosters.
    Rababa'h AM; Abedalqader NN; Ababneh M
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(23):7516-7525. PubMed ID: 34919254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COVID-19 vaccine hesitancy and social contact patterns in Pakistan: results from a national cross-sectional survey.
    Quaife M; Torres-Rueda S; Dobreva Z; van Zandvoort K; Jarvis CI; Gimma A; Zulfiqar W; Khalid M; Vassall A
    BMC Infect Dis; 2023 May; 23(1):321. PubMed ID: 37170085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beliefs, barriers and hesitancy towards the COVID-19 vaccine among Bangladeshi residents: Findings from a cross-sectional study.
    Hossain MS; Islam MS; Pardhan S; Banik R; Ahmed A; Islam MZ; Mahabub MS; Sikder MT
    PLoS One; 2022; 17(8):e0269944. PubMed ID: 35998135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perceptions, motivation factors, and barriers to a COVID-19 booster immunization in a subpopulation of KSA: A cross-sectional study.
    Abullais SS; Arora S; Parveen S; Mahmood SE; Baba SM; Khalid I; Khader MA; Elgib MFA
    Medicine (Baltimore); 2022 Nov; 101(47):e31669. PubMed ID: 36451425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and Drivers of COVID-19 Vaccine Booster Hesitancy Among German University Students and Employees.
    Attia S; Mausbach K; Klugar M; Howaldt HP; Riad A
    Front Public Health; 2022; 10():846861. PubMed ID: 35462827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COVID-19 vaccination hesitancy among Iraqi general population between beliefs and barriers: An observational study.
    Shareef LG; Fawzi Al-Hussainy A; Majeed Hameed S
    F1000Res; 2022; 11():334. PubMed ID: 35529280
    [No Abstract]   [Full Text] [Related]  

  • 36. A qualitative insight into the perceptions and COVID-19 vaccine hesitancy among Pakistani pharmacists.
    Yaseen MO; Saif A; Khan TM; Yaseen M; Saif A; Bukhsh A; Shahid MN; Alsenani F; Tahir H; Ming LC; Amin MU; Suleiman AK; Al-Worafi YM; Baig MR; Saeed Imran M; Jaber AA
    Hum Vaccin Immunother; 2022 Dec; 18(1):2031455. PubMed ID: 35192781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessing the acceptability of COVID-19 vaccine and its booster dose.
    Mubarak S; A'aqoulah A; AlGhawrie H; Albalas S; Innab N
    Immun Inflamm Dis; 2023 Sep; 11(9):e950. PubMed ID: 37773710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The evolution of vaccine hesitancy through the COVID-19 pandemic: A semi-structured interview study on booster and bivalent doses.
    Parsons Leigh J; FitzGerald EA; Moss SJ; Cherak MS; Brundin-Mather R; Dodds A; Stelfox HT; Dubé È; Fiest KM; Halperin DM; Ahmed SB; MacDonald SE; Straus SE; Manca T; Ng Kamstra J; Soo A; Longmore S; Kupsch S; Sept B; Halperin SA
    Hum Vaccin Immunother; 2024 Dec; 20(1):2316417. PubMed ID: 38390696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COVID-19 Booster Vaccine Hesitancy in the Emergency Department.
    Molina MF; Nichol G; Eucker SA; Addo N; Rising K; Arreguin M; Morse D; Pauley A; Chavez CL; O'Laughlin KN; Duber H; Rodriguez RM
    Ann Emerg Med; 2023 Oct; 82(4):509-516. PubMed ID: 37178104
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccination coverage among COVID-19 prevention and control management teams at primary healthcare facilities in China and their attitudes towards COVID-19 vaccine: a cross-sectional online survey.
    Yan YY; Wang HT; Fan TY; Sun XJ; Du ZH; Sun XM
    BMJ Open; 2022 Apr; 12(4):e056345. PubMed ID: 35393315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.